powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1972899615
Shravani Pasupneti
M.D
Pulmonary Disease
Stanford,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
88.5
Quality
87.1
Cost
69.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.57%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
956
Beneficiaries
—
Total drug cost
$96K
Distinct drugs
28
Brand share
13.7%
Top prescribed drugs
Pantoprazole Sodium
124 claims
Sulfamethoxazole/Trimethoprim
85 claims
Acyclovir
75 claims
Rosuvastatin Calcium
68 claims
Prednisone
63 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
318
Unique beneficiaries
—
Total services
788
Distinct HCPCS
9
Medicare payment
$92K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — below median (cohort median 927).